SEC Form 4 · accession 0001104659-17-028423
SYNERGY PHARMACEUTICALS, INC. · SGYP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Gary G Gemignani
Officer — Executive Vice Pres. & CFO
Period of report
May 1, 2017
Accepted (ET)
May 1, 2017 · 4:37 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001347613
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionsF1 | $4.12 | May 1, 2017 | A | 375,000 | A | — | May 1, 2027 | Common Stock | 375,000 | 375,000 | D |
Explanation of responses
- F1125,000 of the stock options vest on each of 4/17/2018, 2019 and 2020.